Vecabrutinib Uses, Dosage, Side Effects and more

Vecabrutinib is under investigation in clinical trial NCT03037645 (Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers).

Trade Name Vecabrutinib
Generic Vecabrutinib
Type
Formula C22H24ClF4N7O2
Weight Average: 529.92
Monoisotopic: 529.1616134
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share